Another exosomal miRNA, miR-1246, was found to be downregulated in prostate cancer cells, but was found to inhibit tumor growth in vivo while inhibiting N-cadherin and vimentin levels in vitro, suggesting a protective role against disease progression for this miRNA [193]. Here, CDH2 is linked to prostate carcinoma.